Aziz Nazha
Expertise in
15
conditions

Dr. Aziz Nazha

Hematology | Hematology Oncology
Jefferson Health
Sidney Kimmel Comprehensive Cancer Center — Cherry Hill
2211 Chapel Avenue, 
Cherry Hill, NJ 
Accepting New Patients
Expertise in
15
conditions
Jefferson Health
Sidney Kimmel Comprehensive Cancer Center — Cherry Hill
2211 Chapel Avenue, 
Cherry Hill, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aziz Nazha is a Hematologist and a Hematologist Oncology provider in Cherry Hill, New Jersey. Dr. Nazha is highly rated in 15 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is currently accepting new patients.

His clinical research consists of co-authoring 132 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Tishreen University
Residency
AtlantiCare Regional Medical Center - City Campus
Specialties
Hematology
Hematology Oncology
Licenses
Internal Medicine in TX
Board Certifications
Medical Oncology
Hematology/Oncology
Fellowships
Cleveland Clinic
University of Texas M.D. Anderson Cancer Center
Hospital Affiliations
Jefferson Cherry Hill Hospital
Jefferson Stratford Hospital
Jefferson Washington Township Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Sidney Kimmel Comprehensive Cancer Center — Cherry Hill
2211 Chapel Avenue, Cherry Hill, NJ 08002
Call: 856-922-5180
Other Locations
Medical Oncology & Infusion Suite - 900 Medical Center Drive
900 Medical Center Drive, Suite 200, Sewell, NJ 08080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Ruxolitinib
Study Phase: Phase 2
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drugs: Palcociclib, Daunorubicin, Cytarabine
Study Phase: Phase 1/Phase 2
A Phase II Study of CPX-351 as a Novel Therapeutic Approach for Patients With Myelodysplastic Syndromes (MDS) After Hypomethylating Agent Failure
A Phase II Study of CPX-351 as a Novel Therapeutic Approach for Patients With Myelodysplastic Syndromes (MDS) After Hypomethylating Agent Failure
Enrollment Status: Terminated
Publish Date: August 15, 2024
Intervention Type: Drug
Study Drug: CPX-351
Study Phase: Phase 2
A Phase Ib Study of RVU120 (SEL120) in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
A Phase Ib Study of RVU120 (SEL120) in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: February 14, 2024
Intervention Type: Drug
Study Drug: RVU120
Study Phase: Phase 1
Phase 2, Randomized, Biomarker-driven Clinical Study in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥30%
Phase 2, Randomized, Biomarker-driven Clinical Study in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥30%
Enrollment Status: Terminated
Publish Date: November 15, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 3 Multicenter Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. Therapy and Control Sub-groups in Older Patients With R/R AML
Phase 3 Multicenter Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. Therapy and Control Sub-groups in Older Patients With R/R AML
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: CPI-613, Cytarabine, Mitoxantrone, Etoposide, Fludarabine, Filgrastim
Study Phase: Phase 3
Targeting TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia (AML) With Azacitidine and Ascorbic Acid
Targeting TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia (AML) With Azacitidine and Ascorbic Acid
Enrollment Status: Completed
Publish Date: August 11, 2021
Intervention Type: Drug
Study Drugs: Azacitidine, Ascorbic Acid
Study Phase: Phase 2
View 6 Less Clinical Trials

132 Total Publications

A Proposed Path to Explaining the Unexplained Anemia of Aging.
A Proposed Path to Explaining the Unexplained Anemia of Aging.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: June 23, 2025
View All 132 Publications
Similar Doctors
Expertise in
25
conditions
Dr. Pierluigi Porcu
Hematology Oncology | Oncology | Hematology
Expertise in
25
conditions
Dr. Pierluigi Porcu
Hematology Oncology | Oncology | Hematology

Jefferson University Physicians

925 Chestnut St, Suite 3, 
Philadelphia, PA 
 (15.4 miles away)
215-955-8874
Languages Spoken:
English
See accepted insurances

Pierluigi Porcu is a Hematologist Oncology specialist and an Oncologist in Philadelphia, Pennsylvania. Dr. Porcu is highly rated in 25 conditions, according to our data. His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
27
conditions
Dr. Stephen J. Schuster
Hematology
Expertise in
27
conditions
Dr. Stephen J. Schuster
Hematology

Abramson Cancer Center Perelman 4th Floor West

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
 (15.9 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Schuster is a Hematologist in Philadelphia, Pennsylvania. Dr. Schuster is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
13
conditions
Dr. Andrew M. Evens
Hematology | Hematology Oncology | Oncology
Expertise in
13
conditions
Dr. Andrew M. Evens
Hematology | Hematology Oncology | Oncology

Rutgers Health-Rwj Scleroderma Program

1 Robert Wood Johnson Pl, 
New Brunswick, NJ 
 (61.6 miles away)
732-828-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Evens is a Hematologist and a Hematologist Oncology provider in New Brunswick, New Jersey. Dr. Evens is highly rated in 13 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Evens is currently accepting new patients.

VIEW MORE Hematologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nazha's expertise for a condition
ConditionClose
  • Elite
  • Acute Myeloid Leukemia (AML)
    Dr. Nazha is
    Elite
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Leukemia
    Dr. Nazha is
    Elite
    . Learn about Leukemia.
    See more Leukemia experts
  • Myelodysplastic Syndrome (MDS)
    Dr. Nazha is
    Elite
    . Learn about Myelodysplastic Syndrome (MDS).
    See more Myelodysplastic Syndrome (MDS) experts
  • Distinguished
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Nazha is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Chronic Myelomonocytic Leukemia (CMML)
    Dr. Nazha is
    Distinguished
    . Learn about Chronic Myelomonocytic Leukemia (CMML).
    See more Chronic Myelomonocytic Leukemia (CMML) experts
  • Advanced
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Nazha is
    Advanced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Adult T-Cell Leukemia
    Dr. Nazha is
    Advanced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Anemia
    Dr. Nazha is
    Advanced
    . Learn about Anemia.
    See more Anemia experts
  • Aplastic Anemia
    Dr. Nazha is
    Advanced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Bone Marrow Aspiration
    Dr. Nazha is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Childhood Acute Myeloid Leukemia
    Dr. Nazha is
    Advanced
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
View All 10 Advanced Conditions
  • Experienced
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Nazha is
    Experienced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Promyelocytic Leukemia
    Dr. Nazha is
    Experienced
    . Learn about Acute Promyelocytic Leukemia.
    See more Acute Promyelocytic Leukemia experts
  • Agranulocytosis
    Dr. Nazha is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Bone Marrow Transplant
    Dr. Nazha is
    Experienced
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Chronic T-Cell Leukemia (CTCL)
    Dr. Nazha is
    Experienced
    . Learn about Chronic T-Cell Leukemia (CTCL).
    See more Chronic T-Cell Leukemia (CTCL) experts
  • Epidermal Nevus
    Dr. Nazha is
    Experienced
    . Learn about Epidermal Nevus.
    See more Epidermal Nevus experts
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Hematologists Cherry Hill, NJ
  3. Dr. Aziz Nazha
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.